Phoenix Biotechnology's Angel - V Round

Phoenix Biotechnology raised a round of funding on June 18, 2014.

Phoenix Biotechnology develops promising agents with minimal or no side effects for targeted therapy of malignant tumor growth. Targeted therapy has recently become the focus in the medical community …

Articles about Phoenix Biotechnology's Angel - V Round: